Literature DB >> 20368678

Trajectory control of PbSe-gamma-Fe2O3 nanoplatforms under viscous flow and an external magnetic field.

Lioz Etgar1, Arie Nakhmani, Allen Tannenbaum, Efrat Lifshitz, Rina Tannenbaum.   

Abstract

The flow behavior of nanostructure clusters, consisting of chemically bonded PbSe quantum dots and magnetic gamma-Fe(2)O(3) nanoparticles, has been investigated. The clusters are regarded as model nanoplatforms with multiple functionalities, where the gamma-Fe(2)O(3) magnets serve as transport vehicles, manipulated by an external magnetic field gradient, and the quantum dots act as fluorescence tags within an optical window in the near-infrared regime. The clusters' flow was characterized by visualizing their trajectories within a viscous fluid (mimicking a blood stream), using an optical imaging method, while the trajectory pictures were analyzed by a specially developed processing package. The trajectories were examined under various flow rates, viscosities and applied magnetic field strengths. The results revealed a control of the trajectories even at low magnetic fields (<1 T), validating the use of similar nanoplatforms as active targeting constituents in personalized medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20368678      PMCID: PMC2882682          DOI: 10.1088/0957-4484/21/17/175702

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  31 in total

1.  Automatic tracking of rolling leukocytes in vivo.

Authors:  Scott T Acton; Klaus Wethmar; Klaus Ley
Journal:  Microvasc Res       Date:  2002-01       Impact factor: 3.514

2.  Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping.

Authors:  Sungjee Kim; Yong Taik Lim; Edward G Soltesz; Alec M De Grand; Jaihyoung Lee; Akira Nakayama; J Anthony Parker; Tomislav Mihaljevic; Rita G Laurence; Delphine M Dor; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni
Journal:  Nat Biotechnol       Date:  2003-12-07       Impact factor: 54.908

3.  Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions.

Authors:  Huading Zhang; Lee R Moore; Maciej Zborowski; P Stephen Williams; Shlomo Margel; Jeffrey J Chalmers
Journal:  Analyst       Date:  2005-02-17       Impact factor: 4.616

4.  Monodisperse water-soluble magnetite nanoparticles prepared by polyol process for high-performance magnetic resonance imaging.

Authors:  Jiaqi Wan; Wei Cai; Xiangxi Meng; Enzhong Liu
Journal:  Chem Commun (Camb)       Date:  2007-10-04       Impact factor: 6.222

5.  Design and development of water-soluble curcumin conjugates as potential anticancer agents.

Authors:  Ahmad Safavy; Kevin P Raisch; Sushma Mantena; Leisa L Sanford; Simon W Sham; N Rama Krishna; James A Bonner
Journal:  J Med Chem       Date:  2007-11-01       Impact factor: 7.446

6.  Red blood cell magnetophoresis.

Authors:  Maciej Zborowski; Graciela R Ostera; Lee R Moore; Sarah Milliron; Jeffrey J Chalmers; Alan N Schechter
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

7.  Analytical model of magnetic nanoparticle transport and capture in the microvasculature.

Authors:  E P Furlani; K C Ng
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2006-06-27

Review 8.  Magnetic nanoparticles and their applications in medicine.

Authors:  Etienne Duguet; Sébastien Vasseur; Stéphane Mornet; Jean-Marie Devoisselle
Journal:  Nanomedicine (Lond)       Date:  2006-08       Impact factor: 5.307

9.  Differences in magnetically induced motion of diamagnetic, paramagnetic, and superparamagnetic microparticles detected by cell tracking velocimetry.

Authors:  Xiaoxia Jin; Yang Zhao; Aaron Richardson; Lee Moore; P Stephen Williams; Maciej Zborowski; Jeffrey J Chalmers
Journal:  Analyst       Date:  2008-09-09       Impact factor: 4.616

Review 10.  Multimodal MRI contrast agents.

Authors:  Luca Frullano; Thomas J Meade
Journal:  J Biol Inorg Chem       Date:  2007-07-21       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.